万维书刊网微信二维码

扫微信,关注编辑QQ!

您的位置:万维书刊网 >>sci/scie期刊 >>医药卫生>>生物病理学

Molecular Medicine(研究方向:生化与分子生物学) (官网万博体育下载网站)

简介
  • 期刊简称待设置
  • 参考译名待设置
  • 核心类别 外文期刊,
  • IF影响因子待设置
  • 自引率待设置
  • 主要研究方向待设置
  • 主要研究方向:

    等待设置主要研究方向
    待设置

    Molecular Medicine(双月刊),创刊于1994年,出版国家为美国。 杂志是发布最新的发现,阐明疾病在分子或生理学水平的发病机制,这可能导致疾病诊断,治疗或预防的具体工具的设计。包含与关键生理或疾病过程的遗传,分子或细胞基础相关的原始材料的手稿如果文章或其基本物质,表格或图形的任何部分已经或将不会在其他地方发布或提交,则被视为出版物出现在 分子医学。
    万博官方app下载信息

    万维提示:

    1、万博体育下载网站方式:在线万博体育下载网站。

    2、期刊官网:

    http://molmed.org/molmed

    3、期刊万博体育下载网站:

    https://mc.manuscriptcentral.com/molmed

    4、官网电话:(516562-2114

    5、官网邮箱:editor@molmed.org

    6、信息说明:本刊信息来源于网络,包括 SCI 收录核心期刊,增补期刊,期刊收录数据每年进行更新。本站是公益性网站,为网友万博体育下载网站提供免费服务,由于受相关约束,我们不能提供相关期刊的影响因子、JCR期刊分区等数据供大家参考,造成不便,敬请谅解。

    201754日星期四

                          

     

    Author Guidelines

     

    Criteria

    Molecular Medicine is an open access journal that seeks to publish recent original findings that elucidate the pathogenesis of disease at the molecular or physiological level, which may lead to the design of specific tools for disease diagnosis, treatment, or prevention. Manuscripts containing original material relevant to the genetic, molecular, or cellular basis of key physiologic or disease processes are considered for publication if neither the article nor any part of its essential substance, tables, or figures has been or will be published or submitted elsewhere before appearing in Molecular Medicine. Manuscripts published in Molecular Medicine should contain human or animal in vivo or ex vivo data and describe the implications of the results for human disease and medicine, at a level approachable by our broad audience.

     

    Pre-submission Enquiry

    If authors are unsure as to whether or not their manuscript comes within the scope of Molecular Medicine, they may request advice prior to full submission. An abstract or a summary highlighting the originality and significance of the study should be submitted to the Editorial Office via the online submission system: http://mc.manuscriptcentral.com/molmed. When asked for “Manuscript type,” be sure to select “Pre-submission Enquiry.” Pre-submission inquiries sent by email will not be considered.

     

    The pre-submission enquiry service is a courtesy and is not required prior to full submission. Pre-submission enquiries can be difficult to assess reliably and Molecular Medicine Editors cannot make an absolute commitment to have a contribution refereed before seeing the entire paper. Entire papers should not be sent as pre-submission enquiries.

     

    Submission Types

    Molecular Medicine accepts contributions in the following formats: Research Article, Review Article, Commentary, and Letter to the Editor.

     

    Research Article – reports comprehensive data from original experimental research. This type of paper demonstrates original concepts relating to the molecular or physiological basis of human disease. Because critical evaluation and replication of findings are essential to the scientific process, these types of articles include detailed descriptions of all processes and experimental techniques utilized in the study. In some cases, the Editors may commission Research Articles. Word count is approximately 7000 (including abstract [250 words], figures [count as 250 words each, 5-6 figures are typical], and references). The specific format includes the following sections in this order: Title, Running Head, Author Names, Keywords, Abstract, Introduction, Materials and Methods, Results, Discussion, Acknowledgements, Disclosure, Footnotes, References, Tables, Figure Legends, Figures, and Supplementary Data (if applicable).

     

    Review Article – brings together and analyzes available information in a specific field. These submissions include a summary of the topic/field, a description of gaps in knowledge of the topic/field, and synthesis of information to form a testable hypothesis. Reviews discuss recent developments in the topic/field and make projections about the future direction of a particular field. In some cases, the Editors may commission Review Articles. Word count is approximately 7000 (including abstract [250 words], figures [250 words each], and references).

     

    Commentary – commissioned by the Editors. However, in some cases the Editors may consider unsolicited works. Commentaries are professional opinion pieces covering cutting-edge research topics related to disease pathogenesis and the future of medicine. These may also address an issue of concern regarding work published outside of Molecular Medicine. In this case the commentary may be sent to the original authors for a response. While this submission type does not require data, figures, or original research, they may be included to aid in the education of the interdisciplinary audience. Word count is approximately 1500-3000 (including abstract [250 words], figures [250 words each], and references).

     

    Letter to the Editor – addresses an issue of concern regarding work published by Molecular Medicine and may include data that enhances the dialogue surrounding the work. This may be viewed as an open post-publication review of a manuscript. Once received, comments will be reviewed by the Editors and may be sent to the original authors for a response. In some cases an independent reviewer may be asked to assess the comments. Word count is approximately 800 with up to 15 references and 2 figures.

     

    Cover Letter

    A cover letter should accompany each submission. The cover letter should:

     

    include a brief description of the scientific advance and its importance;

    identify the person (with address and telephone/fax number/email) responsible for administrative and scientific issues concerning the manuscript;

    make it clear that the submitted manuscript has been seen and approved by all authors and that no deserving authors have been omitted;

    make it clear that the work is not under consideration elsewhere;

    include a statement that all human and/or animal studies were approved by the appropriate institutional committee;

    include the names and email addresses of three independent potential reviewers;

    note a pre-submission identification number (if applicable);

    state if any figures or images have been adapted or reproduced from prior published work.

    To view a cover letter template, please see the freely available article: L Chipperfield, L Citrome, J Clark, et al. (2010) Authors' Submission Toolkit: A practical guide to getting your research published. Current Medical Research & Opinion. 26:8 p1968-1982. wwwNaNrojournal.com

     

    Manuscripts should be submitted to Molecular Medicine via our online submission system: http://mc.manuscriptcentral.com/molmed

     

    Style Manual

    The entire manuscript should be double-spaced and written in English with the format following the Council of Science Editors reference manual: Scientific Style and Format: The CSE Manual for Authors, Editors, and Publishers, Eighth Edition. Abbreviations may be used for genes, proteins, and other specialized names if spelled out in entirety at the first use. Any additional known names should also be included in the first use. Gene names must be italicized throughout the text.

     

    File Types

    The following file types are NOT supported during submission: shs; exe; pdf; com; vbs; zip and docx. The maximum total size of files (in K) an author can submit is 60000. Five files may be uploaded at once. If you have difficulty submitting your file due to size restrictions please contact editor@molmed.org for assistance.

     

    Non-Native English Authors

    The European Association of Science Editors (EASE) has published multilingual guidelines for non-native English authors and translators. These guidelines are aimed at making scientific communication more efficient worldwide and preventing scientific misconduct. To view the multilingual guidelines please see this website: http://www.ease.org.uk/guidelines/index.shtml.

     

    Format: Research Article

    This specific format includes the following sections in this order: Title, Running Head, Author Names, Keywords, Abstract, Introduction, Materials and Methods, Results, Discussion, Acknowledgements, Disclosure, Footnotes, References, Tables, Figure Legends, Figures, and Supplementary Data (if applicable).

     

    编委会

    编辑 参与

    Betty DiamondMD

    Feinstein医学研究所

    ManhassetNYUSA

     

    编辑人员

     

    撰稿人

    Frederick W AltPhD

    霍华德休斯医学研究所

    儿童医院

    波士顿,MA,美国

     

    Marco E Bianchi

    圣拉斐尔科学研究所

    米兰,意大利

     

    Timothy Billiar

    匹兹堡大学医学院,健康科学学院

    匹兹堡,美国宾夕法尼亚州

     

    Michael Bukrinsky博士,博士

    乔治华盛顿大学

    华盛顿特区,美国 

     

    Anthony Cerami ,美国纽约州Tarrytown

    名誉教授

    名称

     

     

    Nicholas ChiorazziMD

    费恩斯坦医学研究所

    ManhassetNYUSA

     

    Robert J Desnick博士,博士

    西奈山医学院

    纽约,纽约,美国

     

    Charles A Dinarello医学博士

    科罗拉多大学健康科学学院

    丹佛,CO,美国

     

    Hannelore Ehrenreich,医学博士

    马克斯普朗克研究所

    实验医学

    哥廷根,德国

     

    Laurie Glimcher,医学博士

    威尔康奈尔医学

    纽约,纽约,美国

     

    保罗·格林加德博士

    洛克菲勒大学

    纽约,纽约,美国

     

    彼得·克雷格森,医学博士

    费恩斯坦医学研究所

    ManhassetNYUSA

     

    Lars KlareskogMDPhD

    卡罗林斯卡研究所

    斯德哥尔摩,瑞典 

     

    Mike McCune

    加利福尼亚大学博士,旧金山

    旧金山,CA,美国

     

    卡尔·内森,医学博士

    威尔康奈尔医学

    纽约,纽约,美国

     

    Bert W O'MalleyMD

    贝勒医学院

    休斯敦,TX,美国

     

    Athanasios G Papavassiliou

    MDPhD

    雅典大学

    希腊雅典

     

    Arthur B Pardee博士

    达纳法伯癌症研究所

    波士顿,MA,美国

     

    马克·西蒙斯博士

    费恩斯坦医学研究所

    ManhassetNYUSA

     

    Csaba Szabo医学博士

    德克萨斯大学医学科分校

    美国德克萨斯州加尔维斯顿

     

    凯文J TraceyMD

    编辑荣誉荣誉

    Feinstein医学研究所

    Manhasset,纽约州,美国

     

    H Shaw Warren MD

    传染病

    马萨诸塞州总医院CharlestownMA,美国


  • 万维QQ万博体育下载网站交流群    招募志愿者

    版权所有 Copyright@2009-2015豫ICP证合字09037080号

     纯自助论文万博体育下载网站平台    E-mail:eshukan@163.com


  • 万博体育下载网站问答最小化  关闭